#211 Breaking Down MASLD vs. MASH and the MAESTRO-NASH & ESSENCE Trials: Beyond Journal Club Segment

Core IM | Internal Medicine Podcast by Core IM Team

Jun 29, 202633:40Science & Medicine

MASLD affects nearly one in three adults worldwide, yet many patients remain undiagnosed until advanced fibrosis or cirrhosis develops. So, which patients should clinicians actually be screening? When is a FIB-4 enough,...

Related Episodes

Continue listening to more episodes from Core IM | Internal Medicine Podcast.

#221 Colon Cancer Screening After Age 75 5 Pearls Segment Part 3

Oct 21, 2026 - 17:06

“Should you stop screening for colorectal cancer (CRC) at 75?” This episode explores how to individualize...

#220 Colon Cancer Screening Nuances: 5 Pearls Segment Part 2

Oct 8, 2026 - 21:09

“What’s the best way to screen?” This episode breaks down the pros, limitations, and follow-up needs of F...

#219 Updates in Triglycerides

Sep 29, 2026 - 33:31

“The triglycerides are high. Now what?” This episode breaks down a practical approach to elevated TGs, fr...

#218 Early-Onset CRC: 5 Pearls Segment Part 1

Sep 23, 2026 - 15:20

“Too young for colon cancer.” This episode unpacks the red flags of early-onset CRC, from blood in the st...

#217 Treatment for Alcohol Use Disorder: 5 Pearls Segment

Sep 16, 2026 - 37:37

“It didn’t work.” This episode breaks down practical treatment options (dosing options for naltrexone, ac...

#216 Clinician Grief: At the Beside Segment

Sep 8, 2026 - 39:59

Have you ever lost a patient and found yourself thinking about them long after the shift ended? This epis...

#215 Gallbladder & Biliary Testing: 5 Pearls Segment

Aug 25, 2026 - 34:34

How to choose between RUQ ultrasound, CT, HIDA, MRCP, EUS, and ERCP based on the clinical picture? When s...

#214 Hyponatremia Management: A Core IM Classic

Aug 12, 2026 - 44:57

Throwback: Should you really fluid-restrict every patient with SIADH? When can IV fluids make hyponatremi...